Re:Congress asks if developing slightly fewer medicines is O...
by jeffdavis on Monday October 28, 2019 @01:49PM
(#21379526)
"What's really needed there is to make it easier for generics manufacturers to get regulatory approval."
That seems like a sensible solution to the extent the quality/safety itself is not compromised. For instance maybe there is difficulty importing from other countries, but there should be no problem importing regular insulin from Germany, for instance.
Then, because most people do actually have insurance, the insurance pays for the more expensive version and so that's the only one anybody makes. The market for "regular" insulin is limited to people without insurance, which isn't a big enough market to justify all the regulatory work needed to manufacture it.
What's really needed there is to make it easier for generics manufacturers to get regulatory approval.